For the quarter ending 2026-03-31, GEHC had -$2,227M decrease in cash & cash equivalents over the period. $204M in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | -1,477 | - | 953 | 935 |
| Net income from continuing operations | - | 602 | 1,552 | - |
| Depreciation of property, plant, and equipment | 78 | 74 | 75 | 72 |
| Amortization of intangible assets | 75 | 72 | 73 | 76 |
| Gain on remeasurement of nihon medi-physics equity method investment | 0 | 0 | 0 | 0 |
| Net periodic postretirement benefit plan (income) expense | -47 | -59 | -70 | -68 |
| Postretirement plan contributions | 97 | 78 | 78 | 84 |
| Share-based compensation | 35 | 36 | 38 | 34 |
| Provision for income taxes | 94 | 219 | 179 | 112 |
| Cash paid during the year for income taxes | 92 | 76 | 83 | 179 |
| Receivables | -141 | 210 | 191 | -104 |
| Inventories | 171 | -75 | 29 | 34 |
| Contract and other deferred assets | 46 | -51 | 63 | 100 |
| Accounts payable | 221 | 209 | -6 | -259 |
| Contract liabilities | 35 | 80 | 24 | 45 |
| Current compensation and benefits | -250 | 123 | 178 | -7 |
| All other operating activities net | -99 | -68 | 82 | -117 |
| Cash from (used for) operating activities continuing operations | - | 1,050 | 937 | - |
| Cash from (used for) operating activities | 382 | - | - | -92 |
| Additions to property, plant and equipment and internal-use software | 178 | 134 | 110 | 86 |
| Dispositions of property, plant, and equipment | - | 0 | - | - |
| Purchases of businesses, net of cash acquired | 2,297 | 99 | 0 | 10 |
| Purchases of investments | 13 | 36 | 54 | 8 |
| All other investing activities net | 13 | 0 | -15 | 118 |
| Cash from (used for) investing activities | -2,500 | -269 | -148 | -223 |
| Net increase (decrease) in borrowings (maturities of 90 days or less) | -1 | 0 | - | 0 |
| Newly issued debt, net of debt issuance costs (maturities longer than 90 days) | 1,152 | 1,240 | 1 | 1,493 |
| Repayments and other reductions (maturities longer than 90 days) | 1,003 | 1,502 | 4 | 4 |
| Dividends paid to stockholders | 16 | 16 | 16 | 16 |
| Repurchase of common stock | 100 | 0 | 100 | 100 |
| Redemption of noncontrolling interests | - | 0 | - | - |
| Net transfers (to) from ge | - | 0 | - | - |
| Proceeds from stock issued under employee benefit plans | 10 | 12 | 4 | 1 |
| Taxes paid related to net share settlement of equity awards | 19 | 1 | 8 | 5 |
| All other financing activities net | -2 | -25 | -41 | -9 |
| Cash from (used for) financing activities | 21 | -293 | -165 | 1,361 |
| Cash from (used for) operating activities discontinued operations | - | 0 | 0 | - |
| Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash | -37 | -2 | -16 | 57 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | -2,227 | 486 | 264 | 1,289 |
| Cash, cash equivalents, and restricted cash at beginning of year | 4,515 | 4,030 | 3,766 | 2,476 |
| Cash, cash equivalents, and restricted cash at end of period | 2,288 | 4,515 | 4,030 | 3,766 |
GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC)